New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 6, 2014
15:37 EDTGILDGilead falls after recalling select lots of HIV drug
Gilead Sciences (GILD) is down about 4% in afternoon trade after the firm initiated a recall of select lots of its Atripla treatment. WHAT'S NEW: According to a post on the FDA's website, Gilead initiated a nationwide recall of of about 39,000 bottles of its Atripla treatment. Atripla is a treatment for HIV-1 infection in adults and children at least 12 years old. The recall relates to the presence of red silicone rubber particulates in the lot. ANALYST REACTION: In a note to investors following the recall, analysts at Deutsche Bank said Gilead management reiterated that the recall is a minor issue. Gilead said a typical quality check found small particles and the company proactively contacted the FDA to issue the voluntary recall of these lots. Gilead also said the recalled product comes from their 3rd party manufacturer in China that only makes this drug and noted it has multiple manufacturers for Atripla. The firm said it would be buyers on any weakness in Gilead shares following the news. Deutsche Bank maintains a Buy rating and $132 price target on shares. PRICE ACTION: In late afternoon trade, shares of Gilead are down $2.99 or 3.61%, to $79.88, though this is off the worst levels of the session.
News For GILD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 28, 2015
09:34 EDTGILDActive equity options trading on open
Subscribe for More Information
08:35 EDTGILDGilead: MAA for fixed-dose Emtricitabine, Tenofovir Alafenamide validated by EMA
Subscribe for More Information
May 27, 2015
16:51 EDTGILDGilead inaugurates new lab and $100M investment
Gilead Sciences' wholly-owned subsidiary Gilead Alberta ULC opened the first of two new laboratory buildings at its Edmonton campus, and announced an additional $100M investment to further expand and upgrade the site as the biopharmaceutical company broadens its pipeline of treatments in areas of unmet medical need. A second laboratory building is under construction and set for completion in the spring of 2016.
13:45 EDTGILDGilead HBV future likely from assets other than GS-4774, says Deutsche Bank
Subscribe for More Information
May 26, 2015
10:46 EDTGILDAnthem sued for denying coverage for Gilead's Harvoni, WSJ says
Subscribe for More Information
May 22, 2015
16:00 EDTGILDOptions Update; May 22, 2015
Subscribe for More Information
May 21, 2015
10:58 EDTGILDDeutsche Bank biotech analyst holds an analyst/industry conference call
Subscribe for More Information
May 20, 2015
09:07 EDTGILDGilead's patent for Hep C drug sofosbuvir challenged by NGO's in five countries
Subscribe for More Information
May 19, 2015
10:09 EDTGILDGilead CFO says 'really excited' about options to grow beyond 2018
Subscribe for More Information
07:56 EDTGILDGilead for Achillion rumor not ridiculous, but highly unlikely, TheStreet says
Subscribe for More Information
07:28 EDTGILDUBS to hold a conference
Global Healthcare Conference is being held in New York on May 18-20 with webcasted company presentations to begin on May 19 at 8 am; not all company presentations may be webcasted. Webcast Link
May 18, 2015
19:43 EDTGILDAnthem Blue Cross sued for limiting Harvoni usage, LA Times says
Subscribe for More Information
16:16 EDTGILDGilead confirms plans to present tomorrow at UBS conference, Feuerstein reports
Subscribe for More Information
14:42 EDTGILDAchillion rises as conference cancellation adds fuel to M&A speculation
Subscribe for More Information
09:36 EDTGILDActive equity options trading on open
Subscribe for More Information
May 15, 2015
16:01 EDTGILDOptions Update; May 15, 2015
iPath S&P 500 VIX Short-Term Futures down 20c to 20.06 Option volume leaders: AAPL BAC FB NFLX TWTR BABA CSCO TSLA MU GILD T MSFT AMZN MCD
11:08 EDTGILDOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).
09:31 EDTGILDAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use